Peking University First Hospital | China
Dr. Haotai Xie is a dedicated clinician and researcher at Peking University First Hospital, specializing in cardiovascular diseases and bioinformatics. With a passion for advancing precision cardiology, Dr. Xie integrates computational approaches into clinical practice, enhancing diagnostic accuracy and therapeutic strategies. His work spans biomarker discovery, algorithm development, and non-invasive myocardial ischemia evaluation. Dr. Xie has authored seven first-author SCI papers in high-impact journals, contributing significantly to cardiovascular medicine and epigenetics.
Professional profile👤
ORCID
Scopus
Strengths for the Awards✨
- Academic Productivity: Published seven first-author SCI papers in prestigious journals like Nucleic Acids Research, Briefings in Bioinformatics, and JAHA, accumulating a total impact factor exceeding 40.
- Innovative Research: Co-developed PhaSepDB and MloDisDB, which have become cornerstone resources in phase separation research, cited in over 50 studies.
- Interdisciplinary Expertise: Bridges cardiovascular medicine and bioinformatics, applying computational methods to improve diagnostic tools and biomarker discovery, enhancing precision cardiology.
- Significant Contributions: Pioneered the characterization of cardiovascular phenotypes in Kleefstra syndrome, leading to evidence-based screening protocols, with direct implications for clinical guidelines and rare disease management.
- Research Impact: Work has advanced the understanding of cardiovascular epigenetics and contributed to earlier diagnosis and more personalized treatment strategies.
🎓 Education
- Doctorate in Clinical Medicine, Peking University First Hospital, China.
💼 Experience
- Doctor, Peking University First Hospital.
- Lead researcher in interdisciplinary projects bridging computational biology and cardiovascular medicine.
- Co-developed PhaSepDB and MloDisDB, pivotal resources for phase separation research.
🔬 Research Interests On Medicine
- Cardiovascular Medicine
- Bioinformatics
- Precision Cardiology
- Biomarker Discovery
- AI-driven Diagnostic Tools
🏆 Awards
- Recognized for sustained academic productivity and innovation in cardiovascular research.
📓 Publications
-
“Association between urinary sodium excretion and all-cause mortality: a cohort study in a Chinese community-based population”
- Year: 2025
- Authors: Haotai Xie, Xinyan Wen, Fangfang Fan, Jia Jia, Yong Huo, Yanjun Gong, Yan Zhang
- Citations: Not available yet (published recently)
-
“Highlighting cardiovascular manifestations of Kleefstra syndrome: literature review and clinical insights”
- Year: 2025
- Authors: Haotai Xie, Pengkang He, Qinhui Sheng, Wei Ma, Yanjun Gong, Yan Zhang, Lin Qiu
- Citations: Not available yet (published recently)
-
“Rethinking the Functional SYNTAX Score Threshold”
- Year: 2024
- Authors: Haotai Xie
- Citations: Not available yet (upcoming publication)
-
“Research Progress and Clinical Value of Subendocardial Viability Ratio”
- Year: 2024
- Authors: Haotai Xie, Lan Gao, Fangfang Fan, Yanjun Gong, Yan Zhang
- Citations: Not available yet (recent publication)
-
“PhaSepDB in 2022: annotating phase separation-related proteins with droplet states, co-phase separation partners and other experimental information”
- Year: 2023
- Authors: Chao Hou, Xinxin Wang, Haotai Xie, Taoyu Chen, Peiyu Zhu, Xiaofeng Xu, Kaiqiang You, Tingting Li
- Citations: Not specified
-
“Application of B-Type Natriuretic Peptide in Neonatal Diseases”
- Year: 2021
- Authors: Haotai Xie, Yixuan Huo, Qinzheng Chen, Xinlin Hou
- Citations: Not specified
-
“MloDisDB: a manually curated database of the relations between membraneless organelles and diseases”
- Year: 2021
- Authors: Chao Hou, Haotai Xie, Yang Fu, Yao Ma, Tingting Li
- Citations: Not specified
🔔 Conclusion
Dr. Haotai Xie exemplifies the fusion of clinical expertise and computational innovation, driving advancements in cardiovascular medicine. His research has not only deepened the understanding of cardiovascular diseases but also paved the way for precision cardiology. With a robust publication record and interdisciplinary approach, Dr. Xie continues to shape the future of cardiovascular health management through groundbreaking discoveries and technological integration.
